Klein M, Poucell S, Arbus G S, McGraw M, Rance C P, Yoon S J, Baumal R
Clin Nephrol. 1983 Oct;20(4):163-71.
Pathologic, clinical and serum complement studies were performed on 18 patients with dense deposit disease (DDD). The patients were divided into 3 groups: group A (10 patients who developed end-stage renal failure within 2.9 +/- 1.0 years of onset) group B (3 patients who developed elevated serum creatinines within 6.8 +/- 4.8 years of onset) and group C (5 patients with no evidence of renal insufficiency after 11.0 +/- 1.4 years of follow-up). Renal biopsies from all patients showed intramembranous, electron-dense deposits in glomerular capillary basement membranes. Most group A and B patients presented with a nephritic and/or nephrotic syndrome and followed an active clinical course. In contrast, group C patients presented with either a nephrotic syndrome or asymptomatic proteinuria +/- hematuria and followed a benign course. Sera from group A and B patients contained reduced concentrations of C3 and factor B and large amounts of C3 nephritic factor (NeF) activity. In contrast, serum of group C patients contained normal amounts of C3 and factor B and low levels of C3 NeF activity. These studies show that some patients with DDD (group C) have a benign illness and that they can be identified by serum levels of C3, factor B and C3 NeF activity.
对18例致密沉积物病(DDD)患者进行了病理、临床和血清补体研究。患者分为3组:A组(10例在发病后2.9±1.0年内发展为终末期肾衰竭的患者)、B组(3例在发病后6.8±4.8年内血清肌酐升高的患者)和C组(5例在随访11.0±1.4年后无肾功能不全证据的患者)。所有患者的肾活检均显示肾小球毛细血管基底膜内有膜内电子致密沉积物。大多数A组和B组患者表现为肾炎和/或肾病综合征,临床病程呈活动期。相比之下,C组患者表现为肾病综合征或无症状蛋白尿±血尿,病程呈良性。A组和B组患者的血清中C3和B因子浓度降低,且有大量C3肾炎因子(NeF)活性。相比之下,C组患者的血清中C3和B因子含量正常,C3 NeF活性水平较低。这些研究表明,一些DDD患者(C组)病情良性,可通过血清C3、B因子和C3 NeF活性水平进行识别。